Last year, the World Health Organization (WHO) issued its first guideline endorsing GLP-1 therapies for the long-term treatment of obesity, recognizing it as a chronic disease and recommending these agents as part of comprehensive management strategies that include diet, physical activity, and structured care
JOIN OUR COMMUNITY Receive tips on wellness and nutrition, healthy food recipes, amazing workouts, events that bring our community together, and special offers directly to your inbox
BPC-157 Compared to Other Healing Approaches Placing BPC-157 in context with other healing interventions helps evaluate its risk-benefit profile more clearly
American Association of Clinical Endocrinology consensus statement: comprehensive type 2 diabetes management algorithm - 2023 update
doi: 10.3390/pharmaceutics17010136 166 KauravMGautamLMinzS